🇺🇸 FDA
Patent

US 11192903

Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

granted A61KA61K51/0478A61K51/1203

Quick answer

US patent 11192903 (Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K51/0478, A61K51/1203